Comparative proteomics identified statistically robust overexpression of several inflammatory cytokines, specifically IL6, IL18, CCL7, CXCL10, and CXCL11, which could be targeted to prevent untoward immune-inflammatory effects in COVID-19 patients. The gene discussed is IL18; the disease is COVID-19.